Profil bibliographique

Yolba Smit

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

52Publications signalées

1098Citations signalées

3Affiliations récentes

Institutions déclarées

Radboud University Nijmegen Radboud University Medical Center Radboud Institute for Molecular Life Sciences

Domaines associés

Chronic Myeloid Leukemia TreatmentsPsychotherapy Techniques and ApplicationsAcute Myeloid Leukemia ResearchTreatment of Major DepressionColorectal Cancer Surgical Treatments

Publications récentes

Accès ouvert 2026 articleOpenAlex

Feasibility and Implementation of an eHealth Dashboard for the Remote Monitoring of Dutch Patients With Chronic Myeloid Leukemia: Multimethods Approach

Lynn Verweij, Julie E M Swillens, Sanne J J P M Metsemakers, Yolba Smit et autres

0 citationsJMIR Cancer

Accès ouvert 2026 articleOpenAlex

Patients’ and healthcare providers’ views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study

Dina Nienke Lokhorst, Bart van den Bemt, Yolba Smit, R Hermens et autres

0 citationsThe Oncologist

2026 bookOpenAlex

Modernising toxicity monitoring in chronic myeloid leukaemia

Yolba Smit

0 citationsRadboud University Press eBooks

Accès ouvert 2026 articleOpenAlex

Decisional needs among patients and physicians in the treatment of chronic myeloid leukaemia: a qualitative analysis in the Netherlands

Simone Mingels, M Cloots, Yolba Smit, Nicole M A Blijlevens et autres

2 citationsBMJ Open

Accès ouvert 2025 articleOpenAlex

Interim analysis of a multicenter study on patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: the RODEO study

Dina Nienke Lokhorst, Yolba Smit, Bart J. F. van den Bemt, Rosella Hermens et autres

0 citationsHaematologica

2025 conference-abstractOpenAlex

HSD66 Environmental Impact of Digital Remote Care Versus Standard Care for CML Patients

Sanne J J P M Metsemakers, Rosella Hermens, Yolba Smit, Geneviève I. C. G. Ector et autres

0 citationsValue in Health

Accès ouvert 2025 reviewOpenAlex

Patient-reported toxicity symptoms during tyrosine kinase inhibitor treatment in chronic myeloid leukemia: a systematic review and meta-analysis

Yolba Smit, Pien Scheuter, Jeroen J. W. M. Janssen, Eduardus F. M. Posthuma et autres

2 citationsSupportive Care in Cancer

Accès ouvert 2025 articleOpenAlex

Benefits and Limitations of Real‐World Patient‐Reported Toxicity Symptom Monitoring for Guidelines and Care, as Perceived by Patients, Clinicians, and Guideline Developers

Yolba Smit, L. Verweij, Alan Currie, Jeroen J. W. M. Janssen et autres

0 citationsCancer Medicine

Accès ouvert 2023 reviewOpenAlex

Measuring chronic myeloid leukaemia TKI-related toxic effects in the real world: a systematic review and critical assessment of content validity of patient-reported outcome measures

Yolba Smit, Sanne J J P M Metsemakers, Jeroen J. W. M. Janssen, Eduardus F. M. Posthuma et autres

10 citationsThe Lancet Haematology

Accès ouvert 2023 articleOpenAlex

PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA

Melissa F. Djodikromo, Charlotte L. Bekker, Rosella Hermens, Yolba Smit et autres

0 citationsHemaSphere

Accès ouvert 2023 articleOpenAlex

Patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia (RODEO study): study protocol for a prospective, multicentre, single-arm trial

Melissa F. Djodikromo, Rosella Hermens, Bart JF van den Bemt, Yolba Smit et autres

7 citationsBMC Cancer

Accès ouvert 2023 articleOpenAlex

Effectiveness of digital care platform CMyLife for patients with chronic myeloid leukemia: results of a patient-preference trial

Lynn Verweij, Geneviève I. C. G. Ector, Yolba Smit, Bas van Vlijmen et autres

11 citationsBMC Health Services Research

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.